MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 598507 | Name: Lactogangliotetraosylceramide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lactogangliotetraosylceramide is a leukemia-associated antigen having a novel branching structure.

Chemical Structure

Lactogangliotetraosylceramide
Lactogangliotetraosylceramide
CAS#107221-01-2

Theoretical Analysis

MedKoo Cat#: 598507

Name: Lactogangliotetraosylceramide

CAS#: 107221-01-2

Chemical Formula: C70H129N3O23

Exact Mass: 1379.9017

Molecular Weight: 1380.80

Elemental Analysis: C, 60.89; H, 9.42; N, 3.04; O, 26.65

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Lactogangliotetraosylceramide; LcGg4;
IUPAC/Chemical Name
N-((2R,3S,E)-1-(((2R,3S,4R,5R,6R)-5-(((2R,3R,4S,5S,6R)-4-(((2R,3R,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-(((2S,3S,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxyoctadec-4-en-2-yl)tetracosanamide
InChi Key
YAVBLHXWKRSXJS-AUHMYXHSSA-N
InChi Code
InChI=1S/C70H129N3O23/c1-5-7-9-11-13-15-17-19-20-21-22-23-24-25-26-28-30-32-34-36-38-40-54(81)73-48(49(80)39-37-35-33-31-29-27-18-16-14-12-10-8-6-2)45-89-69-62(87)61(86)64(52(43-76)92-69)94-70-63(88)66(96-68-56(72-47(4)79)60(85)58(83)51(42-75)91-68)65(53(44-77)93-70)95-67-55(71-46(3)78)59(84)57(82)50(41-74)90-67/h37,39,48-53,55-70,74-77,80,82-88H,5-36,38,40-45H2,1-4H3,(H,71,78)(H,72,79)(H,73,81)/b39-37+/t48-,49+,50-,51+,52-,53-,55+,56-,57-,58-,59-,60+,61-,62+,63-,64+,65+,66+,67+,68-,69-,70-/m1/s1
SMILES Code
O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H]([C@H](O[C@@H]2CO)O[C@@H]3[C@H](O)[C@H](O)[C@H](OC[C@H]([C@H](/C=C/CCCCCCCCCCCCC)O)NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)O[C@@H]3CO)O)O[C@@H]4[C@H](NC(C)=O)[C@H](O)[C@H](O)[C@H](CO)O4)[C@@H](NC(C)=O)[C@H]1O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,380.80 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shigeta K, Ito Y, Ogawa T, Kirihata Y, Hakomori S, Kannagi R. Monoclonal antibodies directed to chemically synthesized lactogangliotetraosylceramide, a leukemia-associated antigen having a novel branching structure. J Biol Chem. 1987 Jan 25;262(3):1358-62. PubMed PMID: 3805024. 2: Levery SB, Holmes EH, Harris DD, Hakomori S. 1H NMR studies of a biosynthetic lacto-ganglio hybrid glycosphingolipid: confirmation of structure, interpretation of "anomalous" chemical shifts, and evidence for interresidue amide-amide hydrogen bonding. Biochemistry. 1992 Feb 4;31(4):1069-80. PubMed PMID: 1310419.